We provide a wide range of services for radiopharmaceutical businesses of all sizes.
Development of radiochemistry labeling protocol of different radioisotopes such as Gallium-68, Lutetium-177, Copper-64, Actinium-225, Fluorine-18, etc. Development of the quality control method and stabilizing formulations for various radiopharmaceuticals.
Coordinated overseas IIT study, assistance in clinical protocol drafting to assess radiopharmaceuticals’ clinical safety and efficacy, assistance in GMP production for testing articles, and assistance in the approval process from ethic and scientific committee.
Dosimetry calculation from preclinical data, scaling, and clinical dosimetry estimation from imaging study for research purposes.
Preclinical/clinical imaging data processing from DICOM files for research purposes.
GMP production of imaging agent or therapeutic drug, floor plan, instrumentation, and quality assurance proposals, general radiation safety training and retraining.
Design of radiation-base in vitro assay, ex vivo biodistribution, in vivo PET/SPECT imaging, drug efficacy study and validation.